JANX
Janux Therapeutics·NASDAQ
--
--(--)
--
--(--)
JANX fundamentals
Janux Therapeutics (JANX) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.55 (YoY -400.00%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.55
-400.00%
Report date
Aug 7, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Janux Therapeutics (JANX) key financial stats and ratios, covering profitability, financial health, and leverage.
Janux Therapeutics (JANX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Janux Therapeutics (JANX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Janux Therapeutics (JANX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Janux Therapeutics (JANX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Janux Therapeutics (JANX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Janux Therapeutics's revenue and profit?What is Janux Therapeutics's latest dividend and current dividend yield?Did Janux Therapeutics beat or miss consensus estimates last quarter?What guidance did Janux Therapeutics's management provide for the next earnings period?What were the key takeaways from Janux Therapeutics's earnings call?What does Janux Therapeutics do and what are its main business segments?What were the key takeaways from Janux Therapeutics’s earnings call?What is the market's earnings forecast for Janux Therapeutics next quarter?
